PROPRAL

Main information

  • Trade name:
  • PROPRAL 40 mg tablet
  • Dosage:
  • 40 mg
  • Pharmaceutical form:
  • tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • PROPRAL 40 mg tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Propranolol
  • Product summary:
  • Suitability for use in older adult patients Propranololi hydrochloridum Avoid using in older persons. Non-selective beta blocker. Significant adverse effects include sleep disorders, dperession and muscular weakness. Take interactions into account, especially with drugs affecting the conduction pathways of the heart.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 7012
  • Authorization date:
  • 06-06-2006
  • Last update:
  • 26-07-2018